Name |
---|
Characterize the Molecular Profile of Lupus NephritisLN Patients to Understand ThemechanismsContributing to Patient Responsiveness to Soc |
Integrated Analysis of LN Patient Molecular Profiling and Clinical Annotations to Understand LNdisease Heterogeneity for Disease Endotype |
Validate the Association of the Candidate Biomarker Panel Proposed in Table 3-1 With LN Diseasemonitoring |